Alzheimer's Disease Drug Discovery and the Aging Brain
Ottavio Arancio, Professor, Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Columbia University, speaks to Andrea Charles from Pharma IQ, about the goals of his current research, how the landscape for Alzheimer's disease drug discovery has changed in recent years and how novel PDE5 Inhibitors can be used as a therapeutic tool against Alzheimer's disease. Arancio also shares his thoughts on the future of memory research in drug discov...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.